Hillary Clinton to lay out her plan for cutting drug prices
22 September 2015
Senator and presidential candidate Bernie Sanders and his cohort, Rep. Elijah Cummings, have gotten a lot of attention for their proposed legislation to cut spiraling drug prices in the U.S. One person who seems to have noticed is Hillary Clinton, who says she will unveil her own plan this week for controlling the "cost of skyrocketing prescription drugs."
U.K. scientists develop ultrasonic device to better clean medical instruments
22 September 2015
Researchers from the University of Southampton have created an ultrasonic device that creates tiny bubbles to scrub surfaces--thereby reducing the need for additives and heating to achieve effective cleaning. Known as the StarStream, the device, which is already in commercial production by ultrasound cleaning specialist Ultrawave, essentially improves the cleaning power of water.
Australia's new PM looks to biotech for a boom as mining-led growth wanes, WSJ says
22 September 2015
R&D tax incentives combined with a former investment banker as the country's new prime minister could see steady growth in biotech in Australia gain momentum, the Wall Street Journal reports.
Novartis hit by China, emerging market slowdown-CEO on CNBC
21 September 2015
Drugmaker Novartis has been hit by a slowdown in emerging markets, particularly in China, where previously double-digit growth has decelerated to mid-single digits, Chief Executive Joe Jimenez said in an interview with CNBC.
Big Pharma Stock Unappreciated by Analysts Is a Top Performer
21 September 2015
SVB brushes off those nagging worries about a biotech bubble
21 September 2015
Market turbulence around the world hasn't shaken the confidence of Silicon Valley Bank's analysts in the driving force behind a three-year stretch of biotech IPOs. In their recent half-year review, SVB says they're sticking with a prediction of 45 to 55 biotech IPOs for the year as investors continue to hunt down some big returns in a market where safe havens still don't pay very well.
Why launching a new drug first is key
21 September 2015
Lagging behind in launching new medicines means a much smaller market share for pharmaceutical companies — even if they spend just as much on advertising, according to new research from Duke University’s Fuqua School of Business.
How much is first-to-market worth? There's a formula for that
18 September 2015
Researchers at Duke University's Fuqua School of Business not only quantified the gains that await first-to-market meds, but came up with a tool to predict success--or lack of it--for new drugs based on when they hit the market and how much they spend on ads.
Gallup charts another big slide for pharma's public image
18 September 2015
Another day, another survey showing that pharma's reputation stinks in the U.S. This time, though, the survey-taker is Gallup, and while the industry's rating is down significantly from last year, it's not nearly as bad as it was 10 years ago.
How Russia Should Change Its Healthcare System?
18 September 2015
Over the last twenty years, Russia has significantly changed the way it finances healthcare. Before the collapse of the USSR, the nation’s healthcare system had been supported from the budget. June of 1991 marked the birth of health insurance in the country: In that month, the Russian parliament adopted a new law on medical insurance. In 1993, the government established one federal and eighty-nine regional funds for general medical insurance financed by employer contributions.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024